Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice

Carcinogenesis

Volumn 29, Issue 4, 2008, Pages 824-829

  Mutoh, Michihiro ^a,b   Niho, Naoko ^a   Komiya, Masami ^a   Takahashi, Mami ^a   Ohtsubo, Rina ^a   Nakatogawa, Kiyoshi ^b   Ueda, Kentaro ^b   Sugimura, Takashi ^a   Wakabayashi, Keiji ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b Shizuoka Coffein Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; APC PROTEIN; DISODIUM [5 [[6 [4 PHENYL 6 (PHENYLMETHOXY) 2 PYRIMIDINYL] 2 NAPHTHALENYL]OXY]PENTYL]PROPANEDIOATE; DISODIUM [5 [[6 [5 (1,1 DIMETHYLETHYL 2 BENZOXAZOLYL) 2 NAPHTHALENYL]OXY]PENTYL]PROPANEDIOATE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SK 116; SK 216; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG STRUCTURE; EPITHELIUM CELL; GENE EXPRESSION REGULATION; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOHISTOCHEMISTRY; INTESTINE POLYP; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TARGETING; SMALL INTESTINE MUCOSA; STRUCTURE ACTIVITY RELATION; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; INTESTINAL POLYPS; INTESTINE, SMALL; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NF-KAPPA B; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERPINS;

EID: 41849114540     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn028     Document Type: Article

References (28)

1. Le Marchand,L. et al. (1997) Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res., 57, 4787-4794.
2. Abu-Abid,S. et al. (2002) Obesity and cancer. J. Med., 33 73-86.
3. Yamada,K. et al. (1998) Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ. Int. J. Epidemiol., 27, 794-798.
4. Kaye,J.A. et al. (2002) Statin use, hyperlipidaemia, and the risk of breast cancer. Br. J. Cancer, 86, 1436-1439.
5. Otani,T. et al. (2006) Serum triglycerides and colorectal adenoma in a case-control study among cancer screening examinees (Japan). Cancer Causes Control, 17, 1245-1252.
6. Niho,N. et al. (2003) Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands. Cancer Res., 63, 6090-6095.
7. Niho,N. et al. (2003) Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPAR gamma ligand. Cancer Sci., 94, 960-964.
8. Niho,N. et al. (2005) Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice. Proc. Natl Acad. Sci. USA, 102, 2970-2974.
9. Luchtenborg,M. et al. (2004) APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study. Carcinogenesis, 25, 1219-1226.
10. Kortlever,R.M. et al. (2006) Rapid uptake of tyrphostin into A431 human epidermoid cells is followed by delayed inhibition of epidermal growth factor (EGF)-stimulated EGF receptor tyrosine kinase activity. Cell Cycle, 5, 2697-2703.
11. Nilsson,L. et al. (1998) Unsaturated fatty acids increase plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler. Thromb. Vasc. Biol., 18, 1679-1685.
12. Ferran,C. et al. (1995) Inhibition of NF-kappa B by pyrrolidine dithiocarbamate blocks endothelial cell activation. Biochem. Biophys. Res. Commun., 214, 212-223.
13. Eriksson,P. et al. (1998) Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. Arterioscler Thromb. Vasc. Biol., 18, 20-26.
14. Barbareschi,M. et al. (1995) Novel methods for the determination of the angiogenic activity of human tumors. Breast Cancer Res. Treat. 36, 181-192.
15. Bajou,K. et al. (2002) Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression. Int. J. Cancer, 100, 501-506.
16. Sier,C.F. et al. (1994) Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis. Gastroenterology, 107, 1449-1456.
17. Bajou,K. et al. (1998) Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat. Med. 4, 923-928.
18. Sier,C.F. et al. (1991) Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis. Gastroenterology, 101 1522-1528
19. Li,C.F. et al. (2006) An association between the 4G polymorphism in the PAI-1 promoter and the development of aggressive fibromatosis (desmoid tumor) in familial adenomatous polyposis patients. Fam. Cancer, 6, 89-95.
20. Moser,A.R. et al. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science, 247, 322-324.
21. Charlton,P.A. et al. (1996) Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activity. Thromb. Haemost., 75, 808-815.
22. Ploplis,V.A. et al. (2004) Enhanced in vitro proliferation of aortic endothelial cells from plasminogen activator inhibitor-1-deficient mice. J. Biol. Chem., 279, 6143-6151.
23. Jiang,T. et al. (2005) Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J. Biol. Chem., 280, 32317-32325.
24. Norata,G.D. et al. (2007) Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: Molecular mechanisms and gene expression studies. Atherosclerosis, 193, 321-327.
25. Sachinidis,A. et al. (1993) Lipoproteins induce expression of the early growth response gene 1 in vascular smooth muscle cells from rat. Biochem. Biophys. Res. Commun., 192, 794-799.
26. Bahia,L. et al. (2006) Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome. Clinics, 61, 433-440.
27. Kortlever,R.M. et al. (2006) Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat. Cell Biol., 8, 877-884.
28. Li,C.F. et al. (2005) Plasminogen activator inhibitor-1 (PAI-1) modifies the formation of aggressive fibromatosis (desmoid tumor). Oncogene, 24, 1615-1624.